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TheMycobacterium tuberculosis pandemic is a major health problem, further complicated by an increasing incidence of drug-
resistant isolates and the existence of highly transmissible strains, such as those in the Beijing family. Streptomycin (STR)-resis-
tantM. tuberculosis clinical isolates have been analyzed to look for mutations in the rpsL, rrs, and gidB genes. In addition, the
Rv1258c gene, which encodes Tap, an efflux pump that transports STR, has been sequenced. Mutations affecting codons 43 and
88 of the rpsL gene were found in 44.4% of the strains, and 16.7% of the strains carried mutations in the rrs gene, both of which
probably contribute to STR resistance. Many strains presented with mutations in the gidB gene, but the implication of those mu-
tations in STR resistance remains unclear. Interestingly, a cytosine nucleotide insertion between positions 580 and 581 (denomi-
nated Tap580) in the Rv1258c gene has been found in all Beijing isolates included in this study, suggesting that it might be a novel
polymorphism specific to the Beijing family ofM. tuberculosis. A simple and fast restriction fragment length polymorphism
(RFLP)-PCRmethod for detecting the Tap580 insertion has been developed and used to screen a collection of 220 DNA samples
obtained from cultures ofM. tuberculosis isolates and 30 respiratory specimens. In all cases, the Beijing and non-Beijing repre-
sentative samples were identified correctly. Tap580 is a novel polymorphism specific to the highly transmissible Beijing family,
which allows for fast detection of these strains even at the very early stages of infection.
Mycobacterium tuberculosis is the cause of millions of inci-dences of tuberculosis infections and deaths worldwide (1),
many of them among HIV-positive patients. This pandemic is
further complicated by the increased incidence of drug-resistant
strains (1), which generally have accumulated mutations in the
genes that encode drug target or drug-activating enzymes. Never-
theless, there are resistant strains in which no mutations linked to
drug resistance have been identified, hence suggesting unidenti-
fied drug-target proteins or novel mechanisms of drug resistance.
A paradigm is the case of streptomycin (STR), an antituberculosis
drug that is increasingly used due to the rising incidence of multi-
drug-resistant (MDR) and extensively drug-resistant (XDR) strains.
Mutations in the genes rpsL, rrs, and gidB (encoding the S12 ribo-
somal protein, 16S rRNA, and ribosome methyltransferase, respec-
tively) have been found in ca. 70% ofM. tuberculosis isolates that are
resistant to STR; in the rest of STR-resistant M. tuberculosis strains,
the cause of drug resistance remains unknown.
Molecular techniques have allowed for the differentiation of
several lineages and families amongM. tuberculosis strains, which
differ not only in their global geographical distributions, but also
in terms of transmissibility, drug resistance, treatment outcome,
and other factors. The isolates of the Beijing family ofM. tubercu-
losis are characterized by their increased ability to spread and
cause disease and their increased association with drug resistance
in comparison with the levels for non-Beijing strains (2). Because
of this, manymethods have been developed that are aimed at identi-
fying and differentiatingM. tuberculosis Beijing isolates (3–6). There
are severalmethods for identifying Beijing isolates, including spoli-
gotyping, restriction fragment length polymorphism (RFLP) us-
ing IS6110 as a probe, or the presence of a copy of IS6110 in the
dnaA region (7). Other methods are based on the detection of
specific genomic deletions, such as region of difference 105
(RD105) or an intact pks15/1 gene (8). Recently, the detection
of a single-nucleotide polymorphism (SNP) in the Rv2629 gene
by using real-time PCR followed by high-resolution melting
has also been described (3).
In this work, we present an analysis of target mutations in
clinical isolates of M. tuberculosis that are resistant to STR. In
addition, the nucleotide sequence of the Rv1258c gene has been
investigated as a potential STR-resistance determinant, since this
gene encodes the drug efflux pump Tap inM. tuberculosis, which
transports STR and other antibiotics (9–11). A nucleotide inser-
tion in the coding sequence of the Rv1258c gene has been identi-
fied, which does not seem to be associated with resistance to this
drug. Interestingly, this insertion is exclusive to the Beijing family
of M. tuberculosis isolates and has led to the development of a
method for screeningM. tuberculosis strains (using either purified
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DNA or directly on respiratory samples) and reliably identifying
those belonging to the Beijing family of strains.
MATERIALS AND METHODS
M. tuberculosis DNA samples. First, DNA samples of 18 M. tuberculosis
clinical isolates that are resistant to STR and additional drugs (including
several MDR isolates), of the Universidad de Zaragoza culture collection,
along with the control strainH37Rv (which is fully drug susceptible) were
used as a template to amplify and sequence the target genes (rpsL, rrs, gidB,
and Rv1258c). This group included 4 strains that had a spoligotype that is
consistent with being in the Beijing family.
Next, 220 DNA samples fromM. tuberculosis complex clinical isolates
were analyzed, some of them collected recently from hospitals in Huesca,
Zaragoza, Madrid, and Barcelona (Spain), and some others from a Span-
ish national survey on MDRM. tuberculosis that was done between 1998
and 2009. This set included 49 DNA samples having a spoligotype that is
consistent with those of the Beijing family, 158 that were representative of
other M. tuberculosis distinct lineages (Latin American-Mediterranean
[LAM], T, X, S, Haarlem, central Asian [CAS], east African-Indian [EAI],
and others) including 5 isolates of the MTZ strain, a highly transmissible
M. tuberculosis strain that has caused major outbreaks in Zaragoza (12),
and 13 that wereMycobacterium africanum (Table 1). Overall, this collec-
tion included samples that were representative of most of theM. tubercu-
losis genetic lineages that have been described (13). In these samples, the
presence of the novel nucleotide insertion in the Rv1258c gene that is
described in this work was investigated. In a selection of 30 DNA samples
(18 fromHospital Germans Trías i Pujol, Badalona, and 12 fromHospital
General Universitario Gregorio Marañón, Madrid) that originated from
STR-resistant isolates (five of them belong to the Beijing family), the
Rv1258c gene was completely sequenced in order to verify the presence of
the nucleotide insertion in theRv1258c gene that is described in this work,
and to identify other potential mutations.
PCR amplification and sequencing. The primers used for amplifying
and sequencing the genes related to STR resistance, the annealing temper-
ature used in the PCR, and the size of the product are listed in Table 2.
PCRs were performed in a final volume of 50 l using 200 M (each)
deoxynucleoside triphosphate (dNTP), 5 l of buffer (10 PCR buffer;
Applied Biosystems), 1.25 U of AmpliTaq Gold polymerase (Applied Bio-
systems), 0.25 M (each) primer, 5 l of dimethyl sulfoxide, and 2 l of
DNA (20 to 100 ng/l). Amplifications consisted of an initial step at 94°C
for 10 min, followed by 40 cycles of 1 min at 94°C, annealing for 2 min at
the temperatures indicated in Table 2, and extension for 2 min at 72°C,
with a final extension step of 10min at 72°C. All genes were amplified in a
single product, except for the Rv1258c gene, which was amplified in two
overlapping products, one containing the promoter and the first half of
the coding sequence, and the second containing the rest of the gene.
PCR products were purified using ExoSAP-IT (Affymetrix) and se-
quenced using the same primers used for the amplification. Sequences
were then analyzed by comparisonwith that of the referenceH37Rv strain
(Cole et al. [14]; TubercuList database [http://tuberculist.epfl.ch/]).
Screening of nucleotide insertion in Rv1258c gene. First, an internal
fragment of the Rv1258c gene containing the location of the cytosine nu-
cleotide insertion between positions 580 and 581 of the coding sequence
of the Rv1258c gene (denominated Tap580) was amplified using the prim-
ers ctap9 and ctap10 (Table 2). DNA samples were processed for 9 min at
94°C, followed by 35 cycles of 30 s at 94°C, annealing for 30 s at 65°C,
extension at 72°C for 90 s, and final extension at 72°C for 10 min. A
product of 1,052 bp was obtained, which was digested for 1 h at 37°C with
XhoI restriction enzyme, followed by electrophoresis in an 0.8% agarose
gel in Tris-borate-EDTA (TBE) buffer. As a control of endonuclease di-
gestion, PCR products were digested for 1 h at 37°C with PvuII restriction
enzyme, which produces two fragments of 610 and 442 nucleotides for
both Beijing and non-Beijing isolates.
Bioinformatic analysis. Databases of bacterial genomes were ana-
lyzed using the program BLAST at NCBI (National Center for Biotech-
nology Information, http://blast.ncbi.nlm.nih.gov/) to search for a Tap580
TABLE 1 Number of strains belonging to different lineages used in
Tap580 screening
Lineage/speciesa No. of strains
Beijing 49
T 27
LAM 25
Haarlem 18
U 16
CAS 12
EAI 9
S 2
X 1
Not assigned 48
M. africanum 13
Total 220
a LAM, Latin American-Mediterranean lineage; CAS, central Asian lineage; EAI, east
African-Indian lineage.
TABLE 2 Primers used for amplification in this study
Target PCR product (bp) Taa (°C) Primer Sequence (5=¡ 3=) Reference
For amplifying and sequencing
rpsL 501 52 S13 GGCCGACAAACAGAACGT 30
S16 GTTCACCAACTGGGTGAC 30
rrs 1,037 58 264 TGCACACAGGCCACAAGGGA 31
285 GAGAGTTTGATCCTGGCTCAG 31
gidB 977 56 gidB3 GAACGGAAGATCGTCCAC This work
gidB4 CGATAGTTGAAGCCTGGC This work
Rv1258cb 830 58 ctap1 CAATGTGGATTACCGCGAC This work
ctap2 GTCTTGCCGGTAGCCGTC This work
Rv1258cc 902 58 ctap3 CGCAGGTTCCAGACGAAG This work
ctap4 GATCAGCGCGTTGAGTTC This work
For detection of nucleotide insertion
Rv1258c 1,052 65 ctap9 GTTGTTCGCCACGCTGGTCG This work
ctap10 CCAGATCCAGTTCGCGCAG This work
a Ta, annealing temperature.
b 3= region of the Rv1258c gene.
c Promoter and 5= region of the Rv1258c gene.
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insertion in the Rv1258c gene among the sequenced genomes of the M.
tuberculosis complex.
Screening of Tap580 insertion in Rv1258c gene directly in clinical
samples. A blind panel of 30 respiratory samples was assembled by two
hospitals (Servicio de Microbiología, Hospital Universitario Lozano
Blesa, Zaragoza, Spain, and Servicio de Microbiología Clínica y Enfer-
medades Infecciosas, Hospital General Universitario Gregorio Marañón,
Madrid, Spain). This panel included 29 smear-positive and culture-posi-
tive samples from patients diagnosed with tuberculosis caused by Beijing
(2 samples) and non-Beijing (27 samples) strains, and one further sputum
sample that containedMycobacterium fortuitum as a negative control. Of
the samples containingM. tuberculosis, nine contained between 2 and 10
acid-fast bacilli/field, five samples contained between 10 and 100 acid-fast
bacilli/field, and 15 samples contained 100 acid-fast bacilli/field. All
samples were decontaminated byN-acetyl-L-cysteine–NaOH, and a frac-
tion was incubated for 20 min at 80°C to kill the live bacilli and extract
DNA using the GenoLyse kit (Hain Lifescience). The DNA samples were
processed according to the method described above for detecting the
Tap580 insertion in the Rv1258c gene.
RESULTS AND DISCUSSION
Mutations in rpsL, rrs, and gidB genes. In order to find the mu-
tations responsible for STR resistance in 18M. tuberculosis clinical
strains, the genes rpsL, rrs, and gidB, which are known to carry
mutations related to resistance to STR, were sequenced and com-
pared with the sequence of the STR-susceptible H37Rv laboratory
strain available in the TubercuList database (http://tuberculist
.epfl.ch/). All strains analyzed in our study, including the reference
H37Rv strain, had the mutations A363G in rpsL and C299T in
gidB, which have been reported as sequencing errors in the
sequence of H37Rv included in both the TubercuList database
and GenBank accession no. AL123456.2 (15, 16).
The significant mutations found in the strains analyzed in our
study are summarized in Table 3.
Eight of the strains tested (44.4%) carriedmutations in the rpsL
gene, A128G being the mutation that was found in six of them.
The four Beijing strains included in this group carried this muta-
tion, which is the most frequent mutation found in STR-resistant
M. tuberculosis Beijing strains (17, 18). Two other strains (11.1%)
had the mutation A263G.
Four strains (22.2%) harboredmutations in the rrs gene. Three
strains carried the C340T, A324G, or A736G mutation; to our
knowledge, this is the first report onmutations in this region of the
rrs gene. The strain carrying the mutation A736G also carried the
mutation C462T according to TubercuList numbering, a muta-
tion that has been described as C461T in a previous publication
(19). Finally, one strain carried the mutation C492T close to the
530 loop of the secondary structure ofM. tuberculosis 16S rRNA;
this strain is discussed further below.
The role of the GidB protein in conferring high-level STR re-
sistance in M. tuberculosis has been fully characterized (20), al-
though the contribution of certain point mutations in STR resis-
tance is still controversial; it has been speculated that some
mutations in the gidB gene might promote the acquisition of mu-
TABLE 3 Mutations found in the rpsL, rrs, gidB, and Rv1258c genes in strains of the Universidad de Zaragoza culture collection
M. tuberculosis
STR-resistant strain
Mutation found in:
rpsL
rrs DNA
gidB Rv1258c
DNA Protein DNA Protein DNAc Protein
Z-07044 C340T
Z-07047a A128G K43R A276Cb E92D InsC 580–581 194 frameshift
A615Gb Silent
HMS-1838 C413Tb A138V
HCU-2879 A263G K88R
HCU-2934 A128G K43R T47Gb L16R
HCU-2830a A128G K43R A276Cb E92D InsC 580–581 194 frameshift
A615Gb Silent
HMS-1695 A128G K43R C492T T47Gb L16R
HMS-1691 A263G K88R A13del 5 frameshift
HMS-1781 G490C G164R
VEN-4145a A128G K43R A276Cb E92D InsC 580–581 194 frameshift
A615Gb Silent
VEN-1714 T47Gb L16R
C409Gb R137G
VEN-5292 A324G T47Gb L16R
T149C L50P
VEN-2457 T47Gb L16R
VEN-1667 T47Gb L16R
G248C R83P
VEN-2543
VEN-314 C159T Silent
VEN-4237 C462T C159T Silent
A736G
VEN-3748a A128G K43R A276Cb E92D InsC 580–581 194 frameshift
A615Gb Silent
a Strains belonging to the Beijing family.
b Mutations found in susceptible strains (20, 21, 23).
c “InsC 580-581” indicates insertion of a C nucleotide between nucleotides 580 and 581. “A13del” indicates deletion of the A nucleotide at position 13.
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tations in either rpsL or rrs (21). A large number of mutations
(includingmany silentmutations) were found in the gidB gene; in
fact, only four strains had a gidB gene identical to that of H37Rv.
Manymissensemutations have been described in STR-susceptible
strains, such as the mutation T47G (the most frequent mutation
found in our study), which has been reported as being specific to
the Latin American-Mediterranean (LAM) family strains (22); in
fact, the 6 strains carrying thismutation in our study belong to the
LAM family of strains (data not shown). The four Beijing strains
carried two mutations: A276C (E92D), which has been described
as an SNP specific to this family (22), and A615G; both mutations
can be found in STR-susceptible strains (20). In the Beijing
strains, these gidB mutations occur simultaneously with the mu-
tation A128G in the rpsL gene, as mentioned above.
Among the non-Beijing strains, the gidB C413T mutation has
been found in both STR-resistant and -susceptibleM. tuberculosis
isolates (20, 21, 23). One STR-resistant isolate carried the muta-
tionG248C, indicating that itmight lead to resistance to this drug;
however, other mutations in this position (G248T) have been
found in STR-susceptible strains (21). Finally, the only gidBmu-
tation potentially related to resistance to STR is the missense
mutation G490C, since this one was detected in a strain lacking
mutations in the rpsL and rrs genes.
One strain carriedmutations in all three genes; these were rpsL
A128G, rrsC492T, and gidB T47G. In this strain, STR resistance is
due to the mutation rpsL A128G, since the other two mutations
have been found in both STR-resistant and -susceptible isolates.
The mutation rrs C492T, also reported elsewhere as C491T, has
been associated with the LAM3 genetic lineage of M. tuberculosis
(24, 25). This very same genetic lineage of M. tuberculosis also
carries the mutation T47G, as mentioned above (22).
Finally, one of the STR-resistant strains lacked mutations in
any of the three genes rpsL, rrs, and gidB. In three other strains,
only mutations in gidB were found, although these either were
silent or have been described also in STR-susceptible strains,
hence making it unlikely that they make a major contribution to
resistance to this drug. This confirms that othermechanismsmust
contribute to STR resistance inM. tuberculosis.
Mutations in Rv1258c gene. Since STR is a substrate of the
Rv1258c efflux pump (11), we hypothesize that mutations affect-
ing the expression levels of the Rv1258c gene or that change the
kinetic properties of the efflux pump might contribute to STR
resistance. To investigate this further, the Rv1258c gene was am-
plified and sequenced in the 18 samples of M. tuberculosis STR-
resistant clinical strains in which the rpsL, rrs, and gidB genes had
been sequenced. Two different mutations in the Rv1258c gene
were found. One strain has a deletion of the adenine nucleotide in
position 13 (Table 3), producing a frameshift; as a result, a TGA
stop codon ends translation of a peptide of only 10 amino acids.
Four strains have an insertion of a cytosine nucleotide between
positions 580 and 581 (Tap580) (Table 3); this insertion causes a
frameshift mutation from codon 194 onwards, resulting in a
shorter protein (231 amino acids). This protein probably would
not constitute a functional membrane transporter, since it con-
tains only 6 transmembrane segments (TMS) compared with the
12 TMS of the full-length protein (419 amino acids) (Fig. 1). Bac-
FIG 1 Hydrophobicity profile and transmembrane prediction of the Rv1258c proteins ofM. tuberculosisH37Rv (A) and Beijing isolates (B) made by using the
Hidden Markov model (TMHMM Server v2.0; Center for Biological Sequence Analysis, Technical University of Denmark [http://www.cbs.dtu.dk/services
/TMHMM/]).
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terial drug efflux pumps of the major facilitator superfamily have
12 or 14 TMS, which are required for transport activity.
These five strains carrying mutations in the Rv1258c gene also
carried the A263G (K88R) or A128G (K43R)mutation in the rpsL
gene, which is probably responsible for the high-level STR resis-
tance of these strains; then, it is difficult to analyze the contribu-
tion of Rv1258cmutations in resistance to this drug.
Remarkably, the four strains carrying the Tap580 insertion had
been typed as belonging to the Beijing lineage by RFLP and/or
spoligotyping (data not shown). We hypothesized that this might
represent a novel polymorphism specific to the Beijing family. To
test this, the presence of the Tap580 insertion was inspected in 15
genomes of M. tuberculosis available in public databases (NCBI),
including clinical isolates, laboratory strains, such as H37Rv and
H37Ra, and two strains of the Beijing family. Interestingly, only
CCDC5079 and CCDC5081, which belong to the Beijing family
(26), had the Tap580 insertion (Table 4), further supporting that
Tap580 is an insertion that is specific to the Beijing family isolates.
Other species of the M. tuberculosis complex, such as four sub-
strains ofMycobacterium bovis BCG andM. bovis AF2122/97, did
not show the Tap580 polymorphism and had complete identity
with the Rv1258c gene of H37Rv (Table 4).
The Tap580 insertion is present in clinical strains of the Bei-
jing family of isolates. The presence of the Tap580 insertion was
further investigated in different subtypes of the Beijing family of
isolates, and in isolates of other genetic families. For this, a quick
and simple method for detecting the Tap580 insertion was devel-
oped. Between positions 577 and 582 of the Rv1258c gene, the
sequence CTCGAG is the target for XhoI endonuclease; the inser-
tion of a cytosine nucleotide in the Beijing strains results in CTC
GCAG, which is not recognized by this endonuclease (Fig. 2). We
designed two primers for amplifying a 1,052-bp fragment of the
Rv1258c gene, from nucleotides 165 to 1216, which includes the
position of the Tap580 insertion. Digestion of PCR products with
XhoI endonuclease resulted in twoDNA fragments of 413 and 639
bp in the case of non-Beijing strains, whereas PCR products from
Beijing strains remained unaffected (Fig. 2).
Next, a collection of 220 clinical isolates ofM. tuberculosis com-
plex were screened, which included 49 isolates having a spoligo-
type that is consistent with that of the Beijing family. DNA sam-
ples were given random numbers and were blind tested using our
RFLP-PCR method described above. The Tap580 insertion was
present in all Beijing strains and absent in all strains belonging to
other lineages of M. tuberculosis; the Tap580 insertion was also
absent fromM. africanum isolates (Table 1).
Two controls were included in our assays. First, in each exper-
iment, samples of DNA from the laboratory strainM. tuberculosis
H37Rv (which does not belong to the Beijing family of isolates)
and from the M. tuberculosis GC1237 strain (a Beijing isolate re-
cently characterized [27]) were included. The PCR product from
M. tuberculosisH37Rv was cut by XhoI, whereas that ofM. tuber-
culosis GC1237 was not cut, confirming that all steps in the iden-
tification process were carried out satisfactorily. Second, all PCR
products were digested with PvuII restriction enzyme, which cuts
the amplification products of the Rv1258c gene obtained from
both Beijing and non-Beijing samples, demonstrating that the
amplification step is specific to the Rv1258c gene and ruling out
the possibility of unspecific amplifications.
Finally, out of the 220 samples, the Rv1258c gene was se-
quenced in the 30 M. tuberculosis STR-resistant clinical isolates
from Hospital Gregorio Marañón (Madrid, Spain) and Hospital
GermansTrias i Pujol (Badalona, Spain). TheTap580 insertionwas
consistently found in the 5 Beijing strains and was absent in all the
TABLE 4 Search for Tap580 insertion by bioinformatics analysis of
sequenced genomes of theM. tuberculosis complex
Strain Beijing lineage Tap580 insertion
Mycobacterium tuberculosis
H37Ra No No
H37Rv No No
CCDC5079 Yes Yes
CCDC5180 Yes Yes
CDC1551 No No
CTRI-2 No No
F11 No No
KZN 605 No No
KZN 1435 No No
KZN 4207 No No
RGTB327 No No
RGTB423 No No
Strain Erdman ATCC
35801 DNA
No No
UT205 No No
7199-99 No No
Mycobacterium bovis
BCG Pasteur 1173P2 No
BCGMexico No
BCGMoreau RDJ No
BCG Tokyo 172 DNA No
AF2122/97 No
FIG 2 Screening of the Tap580 insertion in Beijing strains. (A) DNA gel electrophoresis showing PCR product with primers ctap9 and ctap10 digested with XhoI.
M, size marker, lambda DNA digested with PstI; 1,M. tuberculosis GC1237 (Beijing); 2,M. tuberculosisH37Rv (non-Beijing). (B) Sequence of the region of the
Rv1258c gene in a Beijing strain (panel 1) andM. tuberculosisH37Rv strain (panel 2) (GenBank accession no. AL123456.2).
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non-Beijing strains, hence validating themethod for screening the
Tap580 insertion. In addition, a deletion of 4 nucleotides spanning
positions 835 and 838 of the Rv1258c gene was found in one of the
Beijing samples, which is located downstreamof the in-frame stop
codon in positions 694 to 696 produced by the Tap580 insertion.
Detection of the Rv1258c nucleotide insertion in clinical
samples. In order to assess the usefulness of this technique for
detecting Beijing strains directly in clinical samples, a blind panel
of 30 respiratory specimens was assembled by the participating
hospitals. This panel included 29 respiratory samples with diverse
bacillary loads and that were culture-positive for M. tuberculosis,
and one sample containing the nontuberculous mycobacterial
speciesM. fortuitum. After isolating DNA from the sputum sam-
ples, the 1,052-bp PCR product was successfully amplified from
28 samples and digested with XhoI endonuclease. Out of these 28
samples, 26 were identified as containing non-BeijingM. tubercu-
losis strains, and two samples were identified as containing M.
tuberculosis strains of the Beijing family, one ofwhichwas detected
in a specimen with low bacillary load. The genetic lineage identi-
fication of the strains included in the panel was confirmed by the
two hospitals that had designed the blind panel. The 1,052-bp
PCR product could not be amplified from two sputum samples;
one contained M. fortuitum, hence demonstrating the specificity
of this method for detectingM. tuberculosis, and the second sam-
ple had a low bacillary load. Since eight of the nine samples with
low bacillary load could be processed by this protocol, we assume
that the failure to obtain the PCR amplification product with this
sample might be due to other reasons.
The precise effect of this nucleotide insertion in the physiology
of M. tuberculosis Beijing isolates remains to be fully elucidated.
Recently, the role of the Rv1258c efflux pump in drug tolerance in
M. tuberculosis has been reported (28). Since the identified single-
nucleotide insertion in the Rv1258c gene in Beijing isolates results
in a truncated, and most probably inactive, protein, this suggests
that isolates carrying this nucleotide insertionmight have a disad-
vantage in terms of drug resistance and drug tolerance compared
with others carrying a fully functional Rv1258c transporter. How-
ever, since Beijing isolates are frequently associated with a higher
propensity to acquire drug resistance, it is conceivable that other
mutations actually compensate for the loss of Rv1258c in this
family ofM. tuberculosis isolates. Examples of compensatory mu-
tations occurring following the acquisition of drug resistance-as-
sociated mutations have been described forM. tuberculosis (29).
In summary, a new genetic polymorphism of M. tuberculosis
Beijing strains has been used to develop a simple and reliable tech-
nique for identifying isolates of this family. Given the higher trans-
missibility rate of this family of strains, which in addition aremore
prone to developing drug resistance, methods for rapid identifi-
cation constitute a very important tool for the control of out-
breaks caused by isolates of the Beijing family. This technique is
fast, since it can be performed directly on clinical specimens and
there is no need to culture strains; this makes it an ideal method
for being implemented in those settings where routine culture of
clinical samples cannot be done. In addition, this technique is easy
to carry out and does not require sophisticated equipment, as only
a thermocycler and DNA electrophoresis system are needed. In
addition, samples can be processed individually or in groups of
any size, and this can easily accommodate the workflow of a clin-
ical laboratory without the need to process samples in groups of a
fixed number. All this, along with the specificity for both the de-
tection ofM. tuberculosis and the identification of the Beijing fam-
ily of strains, makes it ideal for implementation in clinical labora-
tories, especially in those settings with a high incidence of
tuberculosis infections caused by this family of strains.
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